4.7 Article

Effect of vitamin D-3 supplementation on vascular and metabolic health of vitamin D-deficient overweight and obese children: a randomized clinical trial

Journal

AMERICAN JOURNAL OF CLINICAL NUTRITION
Volume 111, Issue 4, Pages 757-768

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ajcn/nqz340

Keywords

vitamin D deficiency; cholecalciferol; 25-hydroxyvitamin D; obesity; children; endothelial function; arterial stiffness; blood pressure; fasting blood glucose; insulin sensitivity

Funding

  1. NCATS NIH HHS [UL1 TR001857] Funding Source: Medline
  2. NHLBI NIH HHS [R01 HL112985] Funding Source: Medline
  3. NIA NIH HHS [P30 AG024827] Funding Source: Medline

Ask authors/readers for more resources

Background: Obese children are vulnerable to vitamin D deficiency and impaired cardiovascular health; vitamin D replenishment might improve their cardiovascular health. Objectives: The aims were to determine, in vitamin D-deficient overweight and obese children, whether supplementation with vitamin D-3 1000 or 2000 IU/d is more effective than 600 IU/d in improving arterial endothelial function, arterial stiffness, central and systemic blood pressure (BP), insulin sensitivity (1/fasting insulin concentration), fasting glucose concentration, and lipid profile and to explore whether downregulation of adipocytokines and markers of systemic inflammation underlies vitamin D effects. Methods: We conducted a randomized, double-masked, controlled clinical trial in 225 10- to 18-y-old eligible children. Change in endothelial function at 6 mo was the primary outcome. Results: Dose-response increases in serum 25-hydroxyvitamin D concentrations were significant and tolerated without developing hypercalcemia. Changes at 3 and 6 mo in endothelial function, arterial stiffness, systemic-systolic BP, lipids, and inflammatory markers did not differ between children receiving 1000 or 2000 IU vitamin D and children receiving 600 IU. Some secondary outcomes differed between groups. Compared with the 600-IU group, central-systolic, central-diastolic, and systemic-diastolic BP was lower at 6 mo in the 1000-IU group [-2.66 (95% CI: -5.27, -0.046), -3.57 (-5.97, -1.17), and -3.28 (-5.55, -1.00) mm Hg, respectively]; insulin sensitivity increased at 3 and 6 mo and fasting glucose concentration declined at 6 mo (-2.67; 95% CI: -4.88, -0.46 mg/dL) in the 2000-IU group. Conclusions: Correction of vitamin D deficiency in overweight and obese children by vitamin D-3 supplementation with 1000 or 2000 IU/d versus 600 IU/d did not affect measures of arterial endothelial function or stiffness, systemic inflammation, or lipid profile, but resulted in reductions in BP and fasting glucose concentration and in improvements in insulin sensitivity. Optimization of children's vitamin D status may improve their cardiovascular health.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available